C.H. Chen's most recent trade in Ambarella Inc was a trade of 2,498 Ordinary Shares done . Disclosure was reported to the exchange on Sept. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2025 | 2,498 | 29,516 (0%) | 0% | 0 | Ordinary Shares | |
| ACM Research Inc (Class A) | Chenming C. Hu | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 17 Mar 2025 | 163,308 | 100,002 (0%) | 0% | 30 | 4,899,240 | Class A Common Stock |
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 3,374 | 27,018 (0%) | 0% | 0 | Ordinary Shares | |
| ACM Research Inc (Class A) | Chenming C. Hu | Director | 12 Aug 2024 | 20,000 | 20,000 | - | - | Stock Option | ||
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 318 | 9,695 | - | - | Phantom Stock Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 455 | 9,377 | - | - | Phantom Stock Unit | |
| Zoetis (Class A) | C. Chen Heidi | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 3,169 | 0 | - | - | Performance Award Unit | |
| Zoetis (Class A) | Heidi Chen C. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 3,169 | 32,379 (0%) | 0% | - | Common Stock | |
| Zoetis (Class A) | Chen C. Heidi | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 2,108 | 1,673 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Chen C. Heidi | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 2,108 | 30,027 (0%) | 0% | - | Common Stock | |
| Zoetis (Class A) | C. Heidi Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 197.32 per share. | 10 Feb 2024 | 1,086 | 31,293 (0%) | 0% | 197.3 | 214,290 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 197.32 per share. | 10 Feb 2024 | 817 | 29,210 (0%) | 0% | 197.3 | 161,210 | Common Stock |
| Zoetis (Class A) | Heidi Chen C. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 707 | 28,185 (0%) | 0% | - | Common Stock | |
| Zoetis (Class A) | C. Chen Heidi | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 707 | 1,416 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | C. Chen Heidi | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 195.75 per share. | 08 Feb 2024 | 266 | 27,919 (0%) | 0% | 195.8 | 52,070 | Common Stock |
| Zoetis (Class A) | Chen Heidi C. | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 6,936 | 6,936 | - | - | Stock Option | |
| Zoetis (Class A) | C. Heidi Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,803 | 1,803 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | C. Chen Heidi | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,169 | 3,169 | - | - | Performance Award Unit | |
| Zoetis (Class A) | Heidi Chen C. | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 115 | 8,922 | - | - | Phantom Stock Unit | |
| Forte Biosciences Inc | Chen Hubert C. | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 7,500 | 90,000 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 7,500 | 96,478 | - | 0 | Common Stock | |
| Forte Biosciences Inc | Hubert Chen C. | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.82 per share. | 01 Jan 2024 | 3,073 | 93,405 | - | 0.8 | 2,525 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2023 | 152 | 8,806 | - | - | Phantom Stock Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Sale of securities on an exchange or to another person at price $ 180.15 per share. | 15 Sep 2023 | 9,905 | 27,478 (0%) | 0% | 180.2 | 1,784,386 | Common Stock |
| ACM Research Inc (Class A) | Chenming C. Hu | Director | 10 Aug 2023 | 24,000 | 24,000 | - | - | Stock Option | ||
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Grant, award, or other acquisition of securities at price $ 1.01 per share. | 31 Jul 2023 | 74,257 | 84,071 | - | 1.0 | 75,000 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 133 | 8,653 | - | - | Phantom Stock Unit | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 7,500 | 12,407 | - | 0 | Common Stock | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 7,500 | 105,000 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.04 per share. | 01 Jul 2023 | 2,593 | 9,814 | - | 1.0 | 2,697 | Common Stock |
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 1,559 | 20,426 (0%) | 0% | 0 | Ordinary Shares | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 144 | 8,519 | - | - | Phantom Stock Unit | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 7,500 | 112,500 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 7,500 | 7,500 | - | 0 | Common Stock | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.01 per share. | 01 Apr 2023 | 2,593 | 4,907 | - | 1.0 | 2,619 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 542 | 8,375 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 779 | 18,867 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 779 | 1,559 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2023 | 120,000 | 120,000 | - | - | Restricted Stock Units | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,841 | 38,385 (0%) | 0% | - | Common Stock | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,841 | 0 | - | - | Performance Award Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,299 | 36,299 (0%) | 0% | - | Common Stock | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,299 | 3,748 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.33 per share. | 11 Feb 2023 | 1,002 | 37,383 (0%) | 0% | 158.3 | 158,647 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.33 per share. | 11 Feb 2023 | 755 | 35,544 (0%) | 0% | 158.3 | 119,539 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 7,834 | 7,834 | - | - | Stock Option | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 2,841 | 2,841 | - | - | Performance Award Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 2,105 | 2,105 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 139 | 7,832 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 779 | 2,338 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 779 | 18,088 (0%) | 0% | - | Ordinary Shares | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2022 | 177 | 7,693 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2022 | 377 | 0 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2022 | 377 | 17,309 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 3,117 | 3,117 | - | - | Restricted Stock Units | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 151 | 7,516 | - | - | Phantom Stock Unit | |
| ACM Research Inc (Class A) | Chenming C. Hu | Director | 30 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option | ||
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 377 | 377 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 377 | 16,932 (0%) | 0% | - | Ordinary Shares | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 388 | 7,365 | - | - | Phantom Stock Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 898 | 6,977 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 377 | 16,555 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 377 | 754 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.92 per share. | 25 Feb 2022 | 5,555 | 16,178 (0%) | 0% | 38.9 | 216,201 | Ordinary Shares |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 5,555 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 13,025 | 0 | - | - | Performance Award Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 13,025 | 39,678 (0%) | 0% | - | Common Stock | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.87 per share. | 12 Feb 2022 | 5,678 | 34,000 (0%) | 0% | 198.9 | 1,129,184 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 3,776 | 27,871 (0%) | 0% | - | Common Stock | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 3,776 | 5,999 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.87 per share. | 12 Feb 2022 | 1,218 | 26,653 (0%) | 0% | 198.9 | 242,224 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 13,025 | 13,025 | - | - | Performance Award Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 6,477 | 39,737 | - | - | Stock Option | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 1,645 | 9,776 | - | - | Restricted Stock Unit | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 111 | 6,078 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 377 | 1,131 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 377 | 10,623 (0%) | 0% | - | Ordinary Shares | |
| Diodes Inc | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 110.30 per share. | 19 Nov 2021 | 4,000 | 25,000 (0%) | 0% | 110.3 | 441,200 | Diodes Incorporated Common Stock |
| Diodes Inc | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 109.39 per share. | 15 Nov 2021 | 14,804 | 29,000 (0%) | 0% | 109.4 | 1,619,454 | Diodes Incorporated Common Stock |
| Diodes Inc | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 108.30 per share. | 15 Nov 2021 | 3,000 | 44,000 (0%) | 0% | 108.3 | 324,900 | Diodes Incorporated Common Stock |
| Diodes Inc | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 108.17 per share. | 15 Nov 2021 | 3,000 | 47,000 (0%) | 0% | 108.2 | 324,517 | Diodes Incorporated Common Stock |
| Diodes Inc | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 108.76 per share. | 15 Nov 2021 | 196 | 43,804 (0%) | 0% | 108.8 | 21,317 | Diodes Incorporated Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Sale of securities on an exchange or to another person at price $ 220.00 per share. | 09 Nov 2021 | 9,446 | 24,095 (0%) | 0% | 220 | 2,078,120 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 9,446 | 33,260 | - | - | Stock Option | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.24 per share. | 09 Nov 2021 | 9,446 | 33,541 (0%) | 0% | 73.2 | 691,825 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Sale of securities on an exchange or to another person at price $ 210.22 per share. | 25 Oct 2021 | 9,446 | 24,095 (0%) | 0% | 210.2 | 1,985,738 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 9,446 | 42,706 | - | - | Stock Option | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.24 per share. | 25 Oct 2021 | 9,446 | 33,541 (0%) | 0% | 73.2 | 691,825 | Common Stock |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2021 | 134 | 5,967 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 22 Sep 2021 | 3,666 | 10,246 (0%) | 0% | 160 | 586,560 | Ordinary Shares |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2021 | 959 | 0 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2021 | 959 | 13,912 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 09 Sep 2021 | 4,000 | 12,953 (0%) | 0% | 140 | 560,000 | Ordinary Shares |
| Diodes Inc | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 96.65 per share. | 07 Sep 2021 | 50,000 | 50,000 (0%) | 0% | 96.6 | 4,832,265 | Diodes Incorporated Common Stock |
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 1,508 | 1,508 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 01 Sep 2021 | 4,000 | 16,953 (0%) | 0% | 120 | 480,000 | Ordinary Shares |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 133 | 5,832 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 958 | 20,953 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 958 | 959 | - | - | Restricted Stock Units | |
| Zoetis (Class A) | Heidi C. Chen | Executive Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2021 | 550 | 24,095 (0%) | 0% | 0 | Common Stock |